Clinical trial
Lipitor Trial To Study The Effect Of Torcetrpib/Atorvastatin To Atorvastatin…
NCT00137462 · Pfizer, Industry · Completed
Key facts
| NCT number | NCT00137462 |
|---|---|
| Title | Lipitor Trial To Study The Effect Of Torcetrpib/Atorvastatin To Atorvastatin Alone. |
| Official title | A Phase 3, Double-Blind, Randomized, Multisite Trial Of The Efficacy, Safety, And Tolerability Of The Fixed Combination Torcetrapib/Atorvastatin Administered Orally, Once Daily For 12 Months, Compared To Atorvastatin Alone, Titrated Based On NCEP ATP-III LDL-C Goals In Subjects With Fredrickson… |
| Lead sponsor | Pfizer, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Hyperlipidemia |
| Intervention type | Drug |
| Interventions | torcetrapib/atorvastatin, atorvastatin |
| Enrollment | 900 |
| Start date | Nov 1, 2004 |
| Completion | Sep 1, 2006 |
| First posted | Aug 29, 2005 |
| Last update posted | Nov 16, 2007 |
| Countries | Canada, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: